FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2944184059> ?p ?o ?g. }

• W2944184059 abstract "Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disorder that causes life threatening renal disease and current therapies are limited with serious side-effects. CYP epoxygenase metabolites of arachidonic acid epoxyeicosatrienoic acids (EETs) demonstrate strong anti-inflammatory and kidney protective actions. We investigated the ability of an orally active EET analog, EET-A to prevent kidney injury in a mouse SLE model. Twenty-weeks old female NZBWF1 (SLE) and age-matched NZW/LacJ (Non SLE) were treated with vehicle or EET-A (10 mg/kg/d, p.o.) for 14 weeks and urine and kidney tissues were collected at the end of the protocol. SLE mice demonstrated marked renal chemotaxis with 30-60% higher renal mRNA expression of CXC chemokine receptors (CXCR) and CXC chemokines (CXCL) compared to Non SLE mice. In SLE mice, the elevated chemotaxis is associated with 5-15 fold increase in cytokine mRNA expression and elevated inflammatory cell infiltration in the kidney. SLE mice also had elevated BUN, serum creatinine, proteinuria, and renal fibrosis. Interestingly, EET-A treatment markedly diminished renal CXCR and CXCL renal mRNA expression in SLE mice. EET-A treatment also reduced renal TNF-α, IL-6, IL-1β, and IFN-γ mRNA expression by 70-80% in SLE mice. Along with reductions in renal chemokine and cytokine mRNA expression, EET-A reduced renal immune cell infiltration, BUN, serum creatinine, proteinuria and renal fibrosis in SLE mice. Overall, we demonstrate that an orally active EET analog, EET-A prevents renal injury in a mouse model of SLE by reducing inflammation." @default.
• W2944184059 created "2019-05-16" @default.
• W2944184059 creator A5001851791 @default.
• W2944184059 creator A5005298031 @default.
• W2944184059 creator A5008738418 @default.
• W2944184059 creator A5075928887 @default.
• W2944184059 creator A5077198825 @default.
• W2944184059 date "2019-05-10" @default.
• W2944184059 modified "2023-09-26" @default.
• W2944184059 title "Epoxyeicosatrienoic Acid Analog EET-A Blunts Development of Lupus Nephritis in Mice" @default.
• W2944184059 cites W1485976886 @default.
• W2944184059 cites W1547377621 @default.
• W2944184059 cites W1656960246 @default.
• W2944184059 cites W1865549920 @default.
• W2944184059 cites W1866887836 @default.
• W2944184059 cites W1881636432 @default.
• W2944184059 cites W1964486606 @default.
• W2944184059 cites W1965348349 @default.
• W2944184059 cites W1973943625 @default.
• W2944184059 cites W1982266855 @default.
• W2944184059 cites W1984974003 @default.
• W2944184059 cites W1996055704 @default.
• W2944184059 cites W2004488054 @default.
• W2944184059 cites W2013332495 @default.
• W2944184059 cites W2019075151 @default.
• W2944184059 cites W2038209584 @default.
• W2944184059 cites W2044904090 @default.
• W2944184059 cites W2060565525 @default.
• W2944184059 cites W2068572274 @default.
• W2944184059 cites W2068811647 @default.
• W2944184059 cites W2074888333 @default.
• W2944184059 cites W2076321944 @default.
• W2944184059 cites W2077594740 @default.
• W2944184059 cites W2078610240 @default.
• W2944184059 cites W2080882856 @default.
• W2944184059 cites W2081275257 @default.
• W2944184059 cites W2088258412 @default.
• W2944184059 cites W2094074845 @default.
• W2944184059 cites W2104459182 @default.
• W2944184059 cites W2119650820 @default.
• W2944184059 cites W2136463259 @default.
• W2944184059 cites W2140220828 @default.
• W2944184059 cites W2144275228 @default.
• W2944184059 cites W2146183794 @default.
• W2944184059 cites W2150396060 @default.
• W2944184059 cites W2159690591 @default.
• W2944184059 cites W2168558696 @default.
• W2944184059 cites W2170037826 @default.
• W2944184059 cites W2273736591 @default.
• W2944184059 cites W2291767268 @default.
• W2944184059 cites W2330990505 @default.
• W2944184059 cites W2467831176 @default.
• W2944184059 cites W2467908004 @default.
• W2944184059 cites W2588367360 @default.
• W2944184059 cites W2593376712 @default.
• W2944184059 cites W2613529089 @default.
• W2944184059 cites W2731771427 @default.
• W2944184059 cites W2884766852 @default.
• W2944184059 cites W4214677758 @default.
• W2944184059 cites W4252094918 @default.
• W2944184059 cites W4313341441 @default.
• W2944184059 doi "https://doi.org/10.3389/fphar.2019.00512" @default.
• W2944184059 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6523399" @default.
• W2944184059 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31133860" @default.
• W2944184059 hasPublicationYear "2019" @default.
• W2944184059 type Work @default.
• W2944184059 sameAs 2944184059 @default.
• W2944184059 citedByCount "16" @default.
• W2944184059 countsByYear W29441840592019 @default.
• W2944184059 countsByYear W29441840592020 @default.
• W2944184059 countsByYear W29441840592021 @default.
• W2944184059 countsByYear W29441840592022 @default.
• W2944184059 countsByYear W29441840592023 @default.
• W2944184059 crossrefType "journal-article" @default.
• W2944184059 hasAuthorship W2944184059A5001851791 @default.
• W2944184059 hasAuthorship W2944184059A5005298031 @default.
• W2944184059 hasAuthorship W2944184059A5008738418 @default.
• W2944184059 hasAuthorship W2944184059A5075928887 @default.
• W2944184059 hasAuthorship W2944184059A5077198825 @default.
• W2944184059 hasBestOaLocation W29441840591 @default.
• W2944184059 hasConcept C126322002 @default.
• W2944184059 hasConcept C13373296 @default.
• W2944184059 hasConcept C134018914 @default.
• W2944184059 hasConcept C203014093 @default.
• W2944184059 hasConcept C2776912625 @default.
• W2944184059 hasConcept C2776914184 @default.
• W2944184059 hasConcept C2779134260 @default.
• W2944184059 hasConcept C2779912601 @default.
• W2944184059 hasConcept C2780091579 @default.
• W2944184059 hasConcept C2780306776 @default.
• W2944184059 hasConcept C2780472472 @default.
• W2944184059 hasConcept C71924100 @default.
• W2944184059 hasConceptScore W2944184059C126322002 @default.
• W2944184059 hasConceptScore W2944184059C13373296 @default.
• W2944184059 hasConceptScore W2944184059C134018914 @default.
• W2944184059 hasConceptScore W2944184059C203014093 @default.
• W2944184059 hasConceptScore W2944184059C2776912625 @default.
• W2944184059 hasConceptScore W2944184059C2776914184 @default.
• W2944184059 hasConceptScore W2944184059C2779134260 @default.
• W2944184059 hasConceptScore W2944184059C2779912601 @default.

• next